
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
07/09/2025 | Q2 | -- | $5.1M | $0.09 | -- | -- |
04/09/2025 | Q1 | -- | $4M | $0.03 | -- | -- |
01/08/2025 | Q4 | -- | $5.8M | $0.16 | -- | -- |
11/13/2024 | Q3 | -- | $12.6M | $0.27 | -- | -- |
07/10/2024 | Q2 | -- | $7.6M | $0.12 | -- | -- |
04/10/2024 | Q1 | -- | $3.2M | $0.00 | -- | -- |
01/12/2024 | Q4 | -- | -- | $0.09 | -- | -- |
11/15/2023 | Q3 | -- | -- | $0.04 | -- | -- |
07/12/2023 | Q2 | -- | -- | $0.14 | -- | -- |
04/12/2023 | Q1 | -- | -- | $0.01 | -- | -- |
01/09/2023 | Q4 | -- | -- | $0.01 | -- | -- |
11/14/2022 | Q3 | -- | -- | $0.23 | -- | -- |
07/11/2022 | Q2 | -- | -- | $0.03 | -- | -- |
04/12/2022 | Q1 | -- | -- | $0.07 | -- | -- |
01/11/2022 | Q4 | -- | -- | $0.06 | -- | -- |
11/09/2021 | Q3 | -- | -- | $0.07 | -- | -- |
07/06/2021 | Q2 | -- | -- | $0.03 | -- | -- |
04/13/2021 | Q1 | -- | -- | $0.72 | -- | -- |
01/05/2021 | Q4 | -- | -- | $0.04 | -- | -- |
11/10/2020 | Q3 | -- | -- | $0.03 | -- | -- |
07/07/2020 | Q2 | -- | -- | $0.00 | -- | -- |
04/07/2020 | Q1 | -- | -- | $0.01 | -- | -- |
01/07/2020 | Q4 | -- | -- | $0.24 | -- | -- |
11/07/2019 | Q3 | -- | -- | $0.12 | -- | -- |
07/08/2019 | Q2 | -- | -- | $0.05 | -- | -- |
04/08/2019 | Q1 | -- | -- | -$0.00 | -- | -- |
01/07/2019 | Q4 | -- | -- | $0.03 | -- | -- |
11/08/2018 | Q3 | -- | -- | $0.02 | -- | -- |
07/06/2018 | Q2 | -- | -- | $0.00 | -- | -- |
04/06/2018 | Q1 | -- | -- | $0.00 | -- | -- |
01/09/2018 | Q4 | -- | -- | -$0.00 | -- | -- |
11/13/2017 | Q3 | -- | -- | -$0.02 | -- | -- |
07/10/2017 | Q2 | -- | -- | -$0.02 | -- | -- |
04/10/2017 | Q1 | -- | -- | -$0.01 | -- | -- |
01/04/2017 | Q4 | -- | -- | -$0.01 | -$0.02 | $0.01 |
11/01/2016 | Q3 | -- | -- | -$0.03 | -- | -- |
07/06/2016 | Q2 | -- | -- | -$0.02 | -- | -- |
04/07/2016 | Q1 | -- | -- | -$0.01 | -- | -- |
01/08/2016 | Q4 | -- | -- | -$0.00 | -- | -- |
11/09/2015 | Q3 | -- | -- | -$0.96 | -$0.01 | -$0.95 |
Pure Cycle reported $5.1M worth of top line sales in its most recent quarter.
Pure Cycle announced earnings per share of $0.09 which represents a beat of analyst forecast a -- per share.
Pure Cycle reported $3.3M that represents $0.13 per share over the last quarter.
Pure Cycle's earnings are forecast to grow from $0.48 per share to -- per share next year representing an increase of --.
Pure Cycle's next earnings date is November 13, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.